On Thursday, Shares of Sequenom, Inc. (NASDAQ:SQNM), lost -1.96% to $2.00.
Sequenom, declared a partnership with the Perinatal Quality Foundation (PQF) to support an educational program and the creation of a Genetic Education Module to assist health care personnel and their patients better understand and navigate the prenatal testing process. The mission of the program is to develop a standardized education and credentialing process for health care personnel providing pre- and post-testing information, and to provide tools and educational resources to allow each woman to make better informed personal genetic testing decisions.
“The Perinatal Quality Foundation welcomes Sequenom’s support of this important nationwide program,” said Mary Norton, M.D., President of the Perinatal Quality Foundation and Professor of Obstetrics, Gynecology, and Reproductive Sciences at University of California, San Francisco. “This critical partnership will greatly assist us in achieving our vision of providing each pregnant woman in the U.S. with access to knowledgeable personnel and educational resources to enable her to choose the most appropriate prenatal testing decisions for administration of her pregnancy.”
The prenatal genetic testing industry has seen noteworthy advancements, counting the availability of cell free DNA (cfDNA) analysis for noninvasive prenatal testing (NIPT), expanded carrier screening and the introduction of chromosomal microarray analysis (CMA). The Genetic Education Module will seek to develop and disseminate information to advance the understanding and appropriate clinical use of these new technologies through the development of objective, evidence-based educational tools and resources that aim to assist a woman make genetic testing decisions that are consistent with her own preferences and values.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally.
Shares of Sterling Bancorp (NYSE:STL), inclined 1.38% to $13.99, during its last trading session.
Sterling National Bank, the principal partner of Sterling Bancorp (STL), declared the addition of Marc Weiss to one of its commercial banking teams as Managing Director. In this role, he will focus on delivering creative and personalized commercial lending solutions to middle market clients across the New York metro region.
Marc joins Sterling from Antwerp Diamond Bank, where he led the effort to establish its New York office and served as Senior Vice President and General Manager. During his tenure at Antwerp Diamond Bank, Marc led a team that managed a loan portfolio in excess of $500 million. He was responsible for business development, expansion of loan products, and fee income opportunities.
“As we continue to build on our commercial banking capabilities for mid-sized companies, we are very happy to welcome Marc to Sterling,” said David S. Bagatelle, Executive Vice President and President-New York Metro Market at Sterling National Bank. “Marc has more than three decades of experience in commercial lending, and we will draw on his expertise to further strengthen our relationships with clients, anticipate their needs, and provide them with the quality tools and personalized service they need to prosper and grow.”
Sterling Bancorp operates as the bank holding company for Sterling National Bank that provides various banking services to commercial, consumer, and municipal clients in the United States.
At the end of Thursday’s trade, Shares of GNC Holdings Inc (NYSE:GNC), gained 0.88% to $45.93.
GNC Holdings declared that Mike Archbold, CEO and Tricia Tolivar, Executive Vice President & CFO would be presenting at Goldman Sachs’ 22nd Annual Global Retail Conference on September 10, 2015 at The Plaza Hotel. The presentation, which is planned for 10:35 am EDT,
GNC Holdings, Inc. operates as a specialty retailer of health and wellness products. The company operates through three segments: Retail, Franchise, and Manufacturing/Wholesale. Its products comprise vitamins, minerals and herbal supplements, sports nutrition products, diet products, and other wellness products.
Finally, Zebra Technologies Corp. (NASDAQ:ZBRA), ended its last trade with -0.69% loss, and closed at $80.13.
The eighth annual installment of the Zebra Technologies Corporation (ZBRA) Global Shopper Study found that shoppers are very interested in Wi-Fi and location-based, in-store services such as mobile coupons (51 percent), shopping maps (45 percent) and associate assistance (41 percent).
These findings support Zebra’s One Store, One Experience campaign - focusing on brand experience, delivery and fulfillment, loyalty, big data and store mobility to transform the connected customer experience. With higher customer expectations, retailers acknowledge that the role of technology has never been greater.
The study identified that more than one-third of shoppers (34 percent) believe they are better connected to real-time information than in-store associates. Meanwhile, 64 percent of shoppers would be willing to purchase more merchandise if they received better customer service and over one-half (52 percent) value retailers who use technology to make the shopping experience more efficient.
Zebra Technologies Corporation, together with its auxiliaries, designs, manufactures, sells, and supports direct thermal and thermal transfer label printers, radio frequency identification (RFID) printer/encoders, dye sublimation card printers, real-time locating solutions, related accessories, and support software worldwide. It products are used principally in automatic identification (auto ID), data collection, and personal identification applications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
